7/22/2022Drug R&D and Product Registration News Digest July 2022 (3)

7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...

7/21/2022A Practical Review of the New Supporting Regulations of China's Anti-M...

7/21/2022A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...

7/21/2022Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...

7/20/2022China's Prospective Payment System: 3 Ways to Prepare

7/20/2022Official Data: Chinese Pharma Growth Slows in H1/2022

7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

7/19/2022China To Establish National Demonstration Zones For IPR Protection

7/19/2022CNIPA: IP to Boost Bio-Economy Development in China

7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...

7/19/2022Brii Bio Announces Strategic Partnership with China Resources Pharma f...

7/19/2022CDE Solicits Comments on the Draft Guidelines for Clinical Development...

7/19/2022CDE Solicits Comments on the Draft FAQs for Rapid Reporting of Safety ...

7/19/2022NHSA Issues New Notice to Further Strengthen Regulation of Medical Ser...

7/18/2022Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...

7/18/2022Beijing's Top Health Official Fired for Corruption

7/18/2022Unicycive Enters License Deal with Lee's Pharma for Renazorb in China ...

7/18/2022Chugai's Osteoporosis Agent Edirol Launched in China

7/18/2022NHC's 2021 Annual Health Sector Development Report (Full Summary)

7/18/2022June Approvals See China's First Greenlight Based Entirely on Real-Wor...

7/18/2022How China's Big Pharma Bet Could Change Intellectual Property Game

7/18/2022Incidence and Mortality Trends of Nasopharynx Cancer from 1990 to 2019...

7/15/2022China's Community Health Centers Are Losing Public Appeal

7/15/2022Chinese Leaders Pledge to Advance Reform and Reduce Public Healthca...

7/15/2022Recent Official and Executive Moves

7/15/2022Drug R&D and Product Registration News Digest July 2022 (2)

7/14/2022FDA Defers Action on BeiGene/Novartis's Tislelizumab for Esophagus Can...

7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg

7/14/2022China's Latest Round of Volume-Based Procurement of Drugs Further Redu...

Page:134/775 Total number of articles:23249: [First][<<] [132] [133] [134] [135] [136] [>>] [End]